Patent · US Active

Heterocyclic amides as kinase inhibitors

US11485710B2 · kind B2 · utility

0Cited by
6References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 22, 2021
Grant dateNov 1, 2022
Priority date—
Expiry dateJan 22, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds having the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.